These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 5838971)
41. [Treatment of angina pectoris with the association of a duodenal heparinoid and )O-(beta-diethylaminoethoxy)phenyl propiophenone]. Loffler AJ; da Ruos HO; Berreta JA; Pagniez N; Salita S; Zunder J Prensa Med Argent; 1966 May; 53(19):1091-6. PubMed ID: 4161786 [No Abstract] [Full Text] [Related]
42. [Our experiences with the beta-adrenolytic preparation Isoptin Knoll A.G]. Zeman B Cas Lek Cesk; 1969 Jul; 108(35):1041-3. PubMed ID: 5802087 [No Abstract] [Full Text] [Related]
43. [Comparative studies of L- as well as DL-oxyfedrine in healthy people and patients with chronic ischemic heart diseases]. Teichmann W; Lukesch KH; Rikirsch P; Schäbitz J; Schmidt GA; Vogel HC; Sziegoleit W; Enke H Z Arztl Fortbild (Jena); 1976 May; 70(10):554-9. PubMed ID: 782052 [No Abstract] [Full Text] [Related]
45. [Coronary arteries and myocardial perfusion in experimental acute vascular occlusion. Influence of pharmacological coronary dilatation]. Hahn N; Felix R; Draznin N; Mayer R; Düx A; Sporbeck G Med Welt; 1971 Oct; 44():1738-40. PubMed ID: 5125834 [No Abstract] [Full Text] [Related]
46. [Application of a coronary vasodilator, Intensain in clinical anesthesia]. Dan K Masui; 1967 Jan; 16(1):61-5. PubMed ID: 6068641 [No Abstract] [Full Text] [Related]
47. [Various aspects of the pharmacology of iproveratril, a new synthetic coronary dilator with anti-arrhythmic value]. Melville KI; Shister HE; Mignault Jde L; Garvey L Union Med Can; 1969 Apr; 98(4):592-6. PubMed ID: 5355792 [No Abstract] [Full Text] [Related]
48. [Consumption of coronary vasodilator agents and beta blockaders in 2 Prague districts]. Balda L; Mikolásek A; Kubát K; Kratochvíl J; Stika L Cesk Zdrav; 1977 May; 25(5):201-6. PubMed ID: 16700 [No Abstract] [Full Text] [Related]
50. [Clinical experience with Irrigor, a new coronary effective substance]. Christmann W Med Welt; 1968 Nov; 46():2559-60. PubMed ID: 5731381 [No Abstract] [Full Text] [Related]
51. [General aspects of a project of a controlled clinical experimentation with coronary-active drug, evaluated on the base of the onset of remission of signs and symptoms]. Rocchi P; Cavrini P Boll Chim Farm; 1972 Sep; 111(9):579-82. PubMed ID: 4565804 [No Abstract] [Full Text] [Related]
52. [Clinical experimentation with Cardiocap in subjects with coronary disease with coronary insufficiency]. Marignani A; Martelli A; Piana G Minerva Cardioangiol; 1973 Sep; 21(9):629-35. PubMed ID: 4745005 [No Abstract] [Full Text] [Related]
58. Vasodilator therapy in coronary artery disease. Part III. Hager WD Ariz Med; 1977 Aug; 34(8):565-7. PubMed ID: 901250 [No Abstract] [Full Text] [Related]
59. [Clinical and electrocardiographic study on the coronary active action of tetranitrooxyethylethylenediamine dinitrate]. Bianchini E; De Maestri C; Rinaldi AR Boll Soc Med Chir Cremona; 1966; 20(2):161-76. PubMed ID: 5961319 [No Abstract] [Full Text] [Related]
60. [Effect of oxyphedrine (Ildamén) in angina pectoris studied in a double-blind trial]. Marner T Ugeskr Laeger; 1970 Oct; 132(44):2071-3. PubMed ID: 4921746 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]